Home Podcasts The Lancet Microbe in conversation with

The Lancet Microbe in conversation with

The Lancet Group 26 Episodes Oct 16, 2026

Editors at The Lancet Microbe, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from using probiotics to reduce Staphylococcus aureus, to phage therapy and monitoring antimicrobial resistance using faecal metagenomes, and more.

Episodes

Hade Ramos and Jenniffer Angulo on Andes virus Oct 16, 2026 1068 Phoebe Ashley-Norman talks with Hade Ramos and Jenniffer Angulo from the Pontificia Universidad Católica de Chile (Santiago, Chile) about Andes virus, and discuss the findings of their recent Lancet Microbe Article titled: "First nationwide full-genome characterisation of human-derived Andes virus in Chile: a retrospective genomic epidemiology study". Read the Article here: https://www.thelancet.c

Maria do Carmo Nunes, Sheila Klassen and Walderez Dutra on Rheumatic Heart Disease Aug 31, 2026 1815 In this episode, we discuss the Series on Rheumatic Heart Disease published jointly by The Lancet Microbe and The Lancet Regional Health – Americas. We cover why this Series matters to the scientific community, how neglected the disease remains, its incidence across the Americas, and how it's managed in the populations most affected. We also examine the clinical and microbiological challenges in d

Luria Leslie Founou on neonatal sepsis in Africa Aug 12, 2026 1381 Phoebe Ashley-Norman talks with Luria Leslie Founou about neonatal sepsis in Cameroon and sub-Saharan Africa more broadly, in conversation around the Lancet Microbe Personal View "Neonatal sepsis in Africa: what are we missing" Read the Personal View here: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(26)00029-7/fulltext Dr Founou is a microbiologist and researcher with a focus

Antimicrobial resistance National Action Plans and the role of microbial genomics with with Kate Baker and Tess Johnson Jun 24, 2026 2033 In this episode, we discuss antimicrobial resistance (AMR) priorities, as outlined in the UK National Action Plan (NAP) for AMR, and how microbial genomics can contribute to meeting them in the UK and beyond. Guests Kate Baker, a researcher at the Department of Genetics, University of Cambridge (Cambridge, UK) and Tess Johnson, a bioethicist at the Ethox Centre of the University of Oxford (Oxford,

Henriette Nielsen on vaginal microbiota transplantation May 25, 2026 1013 Elisa Pucu speaks with Henriette Svarre Nielsen about their recently published randomised controlled trial, “Vaginal microbiota transplantation for treatment of vaginal dysbiosis without the use of antibiotics: a double-blind, randomised controlled trial in women with vaginal dysbiosis.” Together, they explore the study’s key findings, its implications for women’s health, and the growing importanc

Zakiul Hassan and Tahmina Shirin on Nipah virus disease Apr 13, 2026 2221 Phoebe Ashley-Norman talks with Zakiul Hassan and Prof Tahmina Shirin about the findings of "Interpreting the natural history and pathogenesis of Nipah virus disease through clinical data, to inform clinical trial design: a systematic review", by Zakiul Hassan and colleagues. We also discuss Nipah virus disease more broadly, talking about recent phylogenetic findings, diagnostics, therapeutics, va

Claas Kirchhelle and Lloyd Czaplewski on AMR governance and financing Mar 5, 2026 2204 Elena Dalla Vecchia talks with Claas Kirchhelle and Lloyd Czaplewski about the current antimicrobial resistance (AMR) governance (with a historical perspective on how it came to be), the 2015 WHO Global Action Plan (GAP) on AMR and the draft for the 2026 updated GAP, the role of social sciences in addressing AMR, the financing mechanisms in antibiotic research and development (including push and p

Magnus Unemo on Zoliflodacin treatment for gonorrhea Feb 5, 2026 967 Elisa Pucu from The Lancet Microbe interviews Dr. Magnus Unemo of Örebro University about the clinical implications and key findings from his research. They discuss about the the microbiological analysis and whole genome sequencing of treatment failures from the zoliflodacin phase 3 clinical trial for gonorrhea—revealing insights that could change the future of treatment and antibiotic resistance.

Amber Barton on mass drug administration to eradicate yaws in Papua New Guinea Jan 6, 2026 1294 Phoebe Ashley-Norman of The Lancet Microbe speaks to Amber Barton about the neglected tropical disease, yaws. Efforts to eradicate yaws were first made in the 1950s through a WHO and UNICEF campaign that reduced yaws prevalence by 90%, but it remained endemic in some regions. Global efforts involving the mass drug administration of azithromycin continue in pursuit of the WHO 2030 yaws eradication

Britt Koskella on bacteriophages as a signature of microbiome health Dec 22, 2025 1673 Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Britt Koskella about bacteriophages and phageome, their role in modulating the bacteriome, their potential use as signatures of microbiome health and dysbiosis, and hence, indirectly, as markers of host health and disease status. From an ecological perspective, parasites (such as bacteriophages) are key drivers of the evolution of their hosts

Christian Malaka and Livia Patrono on the surveillance of mpox in the Central African Republic Nov 3, 2025 2028 Rebecca Barksby of The Lancet Microbe speaks to Dr Christian Malaka and Dr Livia Patrono on mpox in the Central African Republic and how researchers are using genomic surveillance to provide insights into the epidemiology of the virus. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00101-6/fulltext Continue this conversation on social! Follow us today at.

Sam Lipworth and Nicole Stoesser on genotypic and phenotypic antimicrobial resistance in Escherichia coli Oct 7, 2025 1546 Elena Dalla Vecchia talks with Dr Sam Lipworth and Prof Nicole Stoesser about the challenges and variability in genotypic predictions of antimicrobial resistance in Escherichia coli, about which they have published two papers in The Lancet Microbe: “Exploring uncatalogued genetic variation in antimicrobial resistance gene families in Escherichia coli: an observational analysis” and “Estimating the

Anastasia Theodosiou on controlled human infection with Neisseria lactamica in pregnancy Apr 1, 2025 1806 Rebecca Barksby of The Lancet Microbe speaks to Dr Anastasia Theodosiou about performing a controlled human infection study in pregnant women investigating mother-to-infant transmission of Neisseria lactamica. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00254-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! F

Susan Meiring, Vanessa Quan, and Nelesh Govender on bloodstream infections in neonates in South Africa Feb 25, 2025 1542 Elena Dalla Vecchia of The Lancet Microbe speaks to Susan Meiring, Vanessa Quan, and Nelesh Govender about bloodstream infections in neonates at lower-tier South African hospitals. Read the full paper, Pathogen aetiology and risk factors for death among neonates with bloodstream infections at lower-tier South African hospitals: a cross-sectional study, at https://www.thelancet.com/journals/lanmic/

Laurence Armand-Lefevre and Luc Samison on surveillance of antimicrobial resistant Escherichia coli in humans, chickens, and the environment in Madaga... Aug 5, 2024 1600 Rebecca Barksby of The Lancet Microbe speaks to Professor Laurence Armand-Lefevre and Professor Luc Hervé Samison about implementing the WHO Tricycle Protocol in Madagascar for the surveillance of extended-spectrum β-lactamase producing Escherichia coli in humans, chickens, and the environment. Read the full article: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00228-1/fullt

Zoe Dyson and Philip Ashton on Salmonella enterica serotypes Typhi and Paratyphi A Jul 9, 2024 1895 Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Zoe Dyson and Dr Philip Ashton about the genomic characterisation of population diversity, antimicrobial resistance profiles, and transmission patterns of Salmonella enterica serotypes Typhi and Paratyphi A in Bangladesh, Nepal, and Malawi. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://insta

Edwin Armitage, Saffiatou Darboe, and Lamin Jaiteh on Streptococcus pyogenes May 24, 2024 1649 Elena Dalla Vecchia of The Lancet Microbe speaks to Edwin Armitage, Saffiatou Darboe, and Lamin Jaiteh about Streptococcus pyogenes carriage and transmission in households in The Gambia. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00046-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... h

Martin Hoenigl on climate change and fungal diseases Mar 27, 2024 2182 Rebecca Barksby of The Lancet Microbe speaks with Professor Martin Hoenigl about the impact of climate change and natural disasters on fungal diseases. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00039-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https

Nancy Chow on sporotrichosis Mar 1, 2024 1349 Rebecca Barksby of The Lancet Microbe speaks to Dr Nancy Chow about sporotrichosis and discusses a genomic epidemiology study of this zoonotic fungal disease among people and cats in Brazil. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00364-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at.

Deborah Williamson and Michael Moso on detecting on-SARS-CoV-2 viruses from COVID-19 rapid antigen test devices Feb 12, 2024 1205 Elena Dalla Vecchia of The Lancet Microbe speaks to Deborah Williamson and Michael Moso about non-SARS-CoV-2 respiratory viral detection from COVID-19 rapid antigen test devices. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00375-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://t

Kate Baker on harnessing genomics for antimicrobial resistance surveillance Nov 23, 2023 1222 Rebecca Barksby of The Lancet Microbe speaks to Professor Kate Baker about the challenges, potential, and recommendations for using genomics to monitor antimicrobial resistance. Read the full Series: https://www.thelancet.com/series/amr-genomics?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.

Erica Furhmeister on monitoring antimicrobial resistance using faecal metagenomes Aug 2, 2023 1188 Rebecca Barksby of The Lancet Microbe talks to Dr Erica Furhmeister about monitoring antimicrobial resistance using faecal metagenomes. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00137-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com

Jie Zhou and Anika Singanayagam on their SARS-CoV-2 human challenge study Jun 9, 2023 1253 Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Jie Zhou and Dr Anika Singanayagam about their SARS-CoV-2 human challenge study. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00101-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram

Hanna Ehrlich on antimalarial drug resistance surveillance May 31, 2023 1940 Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Hanna Ehrlich about antimalarial drug resistance surveillance and her recent cross-sectional study using xenomonitoring in Burkina Faso. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00063-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at

Fabrice Somé sur la surveillance de la résistance aux médicaments antipaludiques (en français) May 31, 2023 1937 Elena Dalla Vecchia du The Lancet Microbe converse avec Dr Fabrice Somé sur la surveillance de la résistance aux médicaments antipaludique et son étude récent qui a utilisé la xenosurveillance en Burkina Faso. Pour lire l’article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00063-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social!

Nichola Calvani on gender equity in science Mar 8, 2023 1334 Rebecca Barksby of The Lancet Microbe talks to Dr Nichola Calvani about gender equity in science and Herminthology, an online initiative that produces online profiles of women working in parasitology. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/comp

Michael Otto on using probiotics to reduce Staphylococcus aureus Jan 13, 2023 1242 Rebecca Barksby of The Lancet Microbe talks to Dr Michael Otto and his and his collaborators’ placebo-controlled phase 2 trial that used the probiotic Bacillus subtilis to reduce Staphylococcus aureus in adults who were colonised by the bacteria in the Songkhla region of Thailand. Read the full article: Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand Continue this

David Cameron on phage therapy Dec 1, 2022 575 Elena Dalla Vecchia of The Lancet Microbe speaks to Dr David Cameron about phage therapy and his and his colleagues’ recent systematic review and meta-analysis of the efficacy of phage therapy in preclinical models of bacterial infection. Read the full article: Efficacy of phage therapy in preclinical models of bacterial infection: a systematic review and meta-analysis Continue this conversation

Samuel Lipworth on Mycobacterium abscessus Sep 28, 2021 803 Jonathan Blott talks to Dr Samuel Lipworth about his and his collaborators' investigation of the epidemiology of Mycobacterium abscessus in England and the risk of person-to-person transmission in health-care settings Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://

Adrian Martineau on Mycobacterium tuberculosis in Ethiopia Jun 2, 2021 850 Rachel Hellier talks to Prof Adrian Martineau about his and his collaborators’ study that identified Mycobacterium tuberculosis complex DNA in CD34-positive peripheral blood mononuclear cells of asymptomatic individuals in Ethiopia, a setting with a high tuberculosis burden. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgr

The Lancet Microbe in conversation with

Episodes

Recommended